Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Current Assets    
Cash and cash equivalents $ 2,465,000 $ 8,968,000
Short-term investments 18,319,000 23,011,000
Prepaid expenses and other current assets 88,000 190,000
Total Current Assets 20,872,000 32,169,000
Operating lease right-of-use asset 190,000
Deposits 9,000
TOTAL ASSETS 21,071,000 32,169,000
Current Liabilities    
Accounts payable 3,325,000 8,220,000
Accrued expenses 1,537,000 1,901,000
Current operating lease liability 106,000
Derivative liability 57,000 138,000
Total Current Liabilities 5,025,000 10,259,000
Non-current operating lease liability 92,000
Total Liabilities 5,117,000 10,259,000
Stockholders’ Equity    
Common stock, par value $0.001, 250,000,000 shares authorized, 32,507,618 shares and 32,061,989 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively 33,000 32,000
Common stock issuable zero shares and 327,298 shares at September 30, 2022 and December 31, 2021, respectively 1,113,000
Additional paid in capital 684,804,000 674,348,000
Accumulated deficit (668,884,000) (653,584,000)
Total Stockholders’ Equity 15,954,000 21,910,000
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY 21,071,000 32,169,000
Series C Preferred Stock [Member]    
Stockholders’ Equity    
Series C - 96,230 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively $ 1,000 $ 1,000